Tag Archives: Financial Results

  • Spectrus

    Spectris Report Results for FY 2015

    Spectris plc (SXS: LSE) is a UK holding company that listed on the London Stock Exchange in 1988. Today they own several companies in the laboratory technologies space including; Malvern Instruments, Particle Measuring Systems, PANalytical, Servomex and NDC Technologies. Spectris reported revenues for 2015 that are flat on a like for like basis, compared with […]

  • Jenoptik Logo

    Jenoptik Achieves New Revenue and Earnings Record

    “After a slow start in the first half-year 2015, our business picked up well in the third and fourth quarters, allowing us to fully achieve our targets for 2015. Thanks to the successful integration of Vysionics, acquired in 2014, our ongoing internationalization process and the consistent execution of our efficiency programs, we managed to increase […]

  • Spectrus

    Spectris Announce Interim Results 2015

    Spectris is one of the UK’s leading suppliers of productivity enhancing instrumentation and controls. They own several well known brands working in the laboratory instrumentation space providing a global footprint. Companies such as Malvern Instruments (Malvern, UK), Particle Measuring Systems (Boulder, CO), PANalytical (Almelo, Netherlands), NDC Technologies (Irwindale, CA) and Servomex (Crowborough, UK) all fall […]

  • Bruker

    Bruker Reports Financial Results for Q1 2015

      Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2015. Bruker’s revenues for the first quarter of 2015 were $353.5 million, a decline of 16.6 percent compared to the first quarter of 2014. Excluding a 2.6 percent net negative effect from acquisitions & divestitures, and an 11.0 percent negative effect […]

  • BD Logo

    BD Announce Full Year Results for 2014

      “Our strong fourth quarter and fiscal year 2014 results mark the conclusion of another successful year for the Company,” said Vincent A. Forlenza, Chairman, CEO and President. “Organic revenue growth continued to accelerate and we delivered a higher quality of earnings while maintaining our ongoing investments to support our innovation strategy. We have built […]

  • FEI Logo

    FEI Reports Third Quarter Results

      FEI Company (Nasdaq:FEIC) reported results for third quarter of 2014. Revenue of $227.8 million was up 4.2% compared to $218.5 million in the third quarter of 2013 and down 3.9% compared to $237.0 million in the second quarter of 2014. Net bookings in the third quarter were $250.1 million with a book-to-bill ratio of […]

  • Pacific Biosciences Logo

    Sales at Pacific Biosciences Up 178% in Q3

      Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported a 178% increase in revenue to $20.6 million for the third quarter ended September 30, 2014, compared to $7.4 million for the third quarter of 2013. Third quarter 2014 revenue included the achievement of the $10.0 million milestone related to Roche along with the $1.7 million quarterly amortization from the upfront Roche payment in addition to […]

  • ThermoFisher Logo

    Sales Rise at Thermo Fisher by 31% in Q3

    “We’re pleased to extend our long track record of consistently delivering strong adjusted EPS growth,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We leveraged our solid top-line results and our culture of operational discipline to achieve excellent performance on the bottom line. I’m also pleased to report that the […]

  • Sales at Waters Up 8% in Q3

      Waters Corporation (NYSE:WAT) reported today third quarter 2014 sales of $493 million, an increase of 8% versus sales of $457 million in the third quarter of 2013. In the quarter, the effect of foreign currency translation was neutral to sales growth. On a GAAP basis, earnings per diluted share (EPS) for the third quarter were $1.34 compared to $1.14 for the third […]

  • Thermo Fisher Reports Q4 and Full Year 2013 Results

      Thermo Fisher Scientific reports Q4 and full year 2013 results today, January 30 2014. Highlights include revenue growth of 6% for the quarter to $3.47 billion in 2013, versus $3.26 billion in 2012 and revenue for full year 2013 grew 5% to $13.09 billion, versus $12.51 billion a year ago. Also, the acquisition of Life Technologies to add complementary genomics, next-generation sequencing […]

  • PerkinElmer Announces Results for Q4 2013

      PerkinElmer announces results for Q4 and full year 2013. Revenues for the full year rose only 2.4% to $2.166 billion but net income rose 135% to $164.8 million from the previous year’s $69.9 million. “We are pleased with our strong finish to the year as we delivered solid performances in adjusted earnings per share growth, […]